Uric Acid in Saliva Is a Biomarker for Body Fat Accumulation in Adolescents
By LabMedica International staff writers Posted on 24 Feb 2020 |

Image: The level of uric acid in saliva is a good indicator of body fat percentage in a study designed to identify reliable biomarkers that can be used to develop quick non-invasive tests for early detection of chronic diseases ((Photo courtesy of Dr. Paula Midori Castelo, Federal University of São Paulo)
The noninvasive measurement of uric acid in saliva has been shown to be an important marker of body fat accumulation in adolescents, which demonstrates the clinical relevance of saliva for detection of early metabolic changes and monitoring of nutritional status.
Uric acid is the end-product of the metabolic breakdown of purines, which are nitrogenous bases in DNA and RNA. It accumulates in the blood and, at much lower concentrations, in the saliva. Although uric acid acts as an antioxidant, when levels become too high in the blood and saliva owing to dysregulated purine degradation, it can lead to a predisposition to develop hypertension, inflammation, and cardiovascular disease.
Investigators at the Federal University of São Paulo (Brazil) and the University of Campinas (Brazil) hypothesized that saliva could provide reliable markers – such as uric acid – able to predict accumulation of body fat in young subjects.
To test this theory, the investigators determined the salivary characteristics of 248 adolescent students (119 girls, 129 boys; 14-17 years of age). Potential participants in the study underwent oral examination to identify those with cavities and/or periodontal disease. Such subjects were excluded from the study, since cavities and periodontal disease are known to influence salivary parameters such as pH, electrolytic composition, and biochemistry. Physical examination of the subjects included height, weight, and body fat percentage (%BF) measured using bioelectric impedance to classify groups as being below or above the %BF cutoff level.
Saliva samples collected at home following a 12-hour fast were assayed by high-performance liquid chromatography (HPLC) for levels of uric acid, cholesterol, 7-ketocholesterol, and 25-hydroxyvitamin D2 and D3 and other metabolites.
Results revealed no significant difference in the levels of 25-hydroxyvitamin D2 and D3, cholesterol, 7-ketocholesterol, phosphorus, calcium, and urea between groups above and below the %BF cutoff, and the variation in salivary flow was small. In contrast, significant gender and group effects were observed for salivary uric acid, which was increased in adolescents with higher %BF and in males (compared to females). Gender showed a significant effect on salivary urea, with lower levels in females.
"The idea is to enable saliva to be more widely used as an alternative biological sample for clinical analysis. The advantage of saliva is that it can be collected several times noninvasively and painlessly, like urine. The study showed the level of salivary uric acid to be a good predictor of body fat percentage even in adolescents considered healthy," said senior author Dr. Paula Midori Castelo, associate professor of biological sciences at the Federal University of São Paulo.
The salivary uric acid study was published in the February 2020 issue of the journal Nutrition Research.
Related Links:
Federal University of São Paulo
University of Campinas
Uric acid is the end-product of the metabolic breakdown of purines, which are nitrogenous bases in DNA and RNA. It accumulates in the blood and, at much lower concentrations, in the saliva. Although uric acid acts as an antioxidant, when levels become too high in the blood and saliva owing to dysregulated purine degradation, it can lead to a predisposition to develop hypertension, inflammation, and cardiovascular disease.
Investigators at the Federal University of São Paulo (Brazil) and the University of Campinas (Brazil) hypothesized that saliva could provide reliable markers – such as uric acid – able to predict accumulation of body fat in young subjects.
To test this theory, the investigators determined the salivary characteristics of 248 adolescent students (119 girls, 129 boys; 14-17 years of age). Potential participants in the study underwent oral examination to identify those with cavities and/or periodontal disease. Such subjects were excluded from the study, since cavities and periodontal disease are known to influence salivary parameters such as pH, electrolytic composition, and biochemistry. Physical examination of the subjects included height, weight, and body fat percentage (%BF) measured using bioelectric impedance to classify groups as being below or above the %BF cutoff level.
Saliva samples collected at home following a 12-hour fast were assayed by high-performance liquid chromatography (HPLC) for levels of uric acid, cholesterol, 7-ketocholesterol, and 25-hydroxyvitamin D2 and D3 and other metabolites.
Results revealed no significant difference in the levels of 25-hydroxyvitamin D2 and D3, cholesterol, 7-ketocholesterol, phosphorus, calcium, and urea between groups above and below the %BF cutoff, and the variation in salivary flow was small. In contrast, significant gender and group effects were observed for salivary uric acid, which was increased in adolescents with higher %BF and in males (compared to females). Gender showed a significant effect on salivary urea, with lower levels in females.
"The idea is to enable saliva to be more widely used as an alternative biological sample for clinical analysis. The advantage of saliva is that it can be collected several times noninvasively and painlessly, like urine. The study showed the level of salivary uric acid to be a good predictor of body fat percentage even in adolescents considered healthy," said senior author Dr. Paula Midori Castelo, associate professor of biological sciences at the Federal University of São Paulo.
The salivary uric acid study was published in the February 2020 issue of the journal Nutrition Research.
Related Links:
Federal University of São Paulo
University of Campinas
Latest Molecular Diagnostics News
- Novel Autoantibody Against DAGLA Discovered in Cerebellitis
- Blood Test Could Identify Patients at Risk for Severe Scleroderma
- Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
- Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease
- Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
- Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
- Blood Test Rules Out Future Dementia Risk
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
- Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
- Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more